Picture of Oncolytics Biotech logo

ONCY — Oncolytics Biotech News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSucker Stock

Brief: Oncolytics Biotech announces first patient treated in Muk Eleven study

Sept 14 (Reuters) - Oncolytics Biotech Inc  ONC.TO : 
    * Oncolytics Biotech announces first patient treated in muk 
eleven study 
    * Oncolytics Biotech  - once maximum tolerated dose has been 
identified with no associated safety issues, 10 additional 
patients will be enrolled at MTD 
    * Oncolytics Biotech Inc - preliminary data for Muk Eleven 
study expected to be available in Q1 2018 
 
Source text for Eikon:  ID:nPn55PMqja  
Further company coverage:  ONC.TO  
 
 ((Bangalore.newsroom@thomsonreuters.com;))

Recent news on Oncolytics Biotech

See all news